REGULATION OF LIMBAL EPITHELIAL STEM CELLS
REGULATION OF LIMBAL EPITHELIAL STEM CELLS
批准号:
2710947
负责人:
SCHEFFER CG TSENG
金额:
$11.07万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-05-01 至 2000-01-27
关键词:
3T3 cells apoptosis cell differentiation cell growth regulation colony stimulating factor cornea disorder corneal epithelium corneal stroma cytokine receptors enzyme linked immunosorbent assay growth factor growth factor receptors hepatocyte growth factor high performance liquid chromatography homeostasis insulinlike growth factor northern blottings polymerase chain reaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The homeostasis of the corneal epithelium, a rapid
self-renewing tissue, is ultimately achieved by orderly proliferation and
differentiation of limbal stern cells (SC). The main objective of this
research proposal is to explore how limbal SC functions are regulated by
their vascularized stromal microenvironment. The healthy state of SC
requires a fine balance of SC functions between SC renewal and SC
differentiation. The former restores SC population, but the latter depletes
it by differentiation into transient amplifying cells (TAC) and then into
post-mitotic differentiated cells. Although both are proliferative
progenitor cells, limbal SC differ from corneal TAX in location, life span,
cell-cycle length and differentiation. The Pi now knows that these mitotic
kinetic differences result from intrinsic differences in the autocrines and
paracrines generated by epithelial-fibroblast interactionsand by access to
serum factors that modulate epithelial cells directly or indirectly via
fibroblasts. In this proposal, he focuses on the role of limbal fibroblasts
in regulating SC renewal by testing the folowing hypotheses: (H1) SC
survival is controlled by an anti-apoptotic survival factor produced by
limbal (also 3T3) fibroblasts under hydrocortisone stimulation. (H2) SC
renewal is dependent on the above anti-apoptotic activity and preferentially
stimulated by keratinocyte growth factor (KGF). The PI has shown that KGF
is preferentially produced by limbal fibroblasts and hepatocyte growth
factor (HGF) is preferentially produced by corneal fibroblasts.
Furthermore, limbal clonal growth is enhanced by KGF HGF IGF-I, but corneal
clonal growth is enhanced by EGF KGF TGF-aHGF in the presence of the
fibroblast-derived anti-apoptotic activity. Thus, he also propose (h3) kgf
acts by stimulating the IGF-IR/IGF-I but not EGF/TGF-a autocrine pathway
during SC renewal. (H4) Selective upregulation of KGF expression by IL-1B
is a mechanism to explain how SC can be activated during wounding. (H5)
TGF-B's differential modulation of KGF and HGF produced by limbal and
corneal fibroblasts is a mechanism to explain how SC are paradoxically
spared or activated while TAC are inhibited, and explains how SC can be
indirectly modulated by non-proteinous factor(s) in the serum. This
research will use biochemical cell and molecular biological techniques to
unravel the pathogenic mechanisms underlying various corneal diseases that
involve limbal SC dysfunctions, and it may, thereby, result in new
therapeutic strategies for treating these difficult diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-angiogenesis of HC-HA Covalent Complex and PTX3 Purified from Fetal Membrane
-
批准号:8122567
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2011
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Tea Tree Oil for Treating Ocular Demodex Infestation
-
批准号:7666623
-
项目类别:
-
资助金额:$11.24万
-
财政年份:2009
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites
-
批准号:8394720
-
项目类别:
-
资助金额:$55.22万
-
财政年份:2009
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Safety and Efficacy of Single-use Cliradex Pads for Ocular Mites
-
批准号:8539626
-
项目类别:
-
资助金额:$63.75万
-
财政年份:2009
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Phase II: Anti-inflammatory and Anti-scarring Actions of Amniotic Membrane Extra
-
批准号:8138414
-
项目类别:
-
资助金额:$49.75万
-
财政年份:2006
-
负责人:SCHEFFER CG TSENG
-
依托单位:
ANTI-SCARRING AND ANTI-INFLAMMATORY EFFECTS OF AMNIOTIC MEMBRANE EXTRACTS
-
批准号:7107568
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2006
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Phase II: Anti-inflammatory and Anti-scarring Actions of Amniotic Membrane Extra
-
批准号:7903691
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2006
-
负责人:SCHEFFER CG TSENG
-
依托单位:
EX VIVO EXPANSION OF RPE CELLS FOR TRANSPLANTATION
-
批准号:6877587
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2005
-
负责人:SCHEFFER CG TSENG
-
依托单位:
TRANSPLANTATION OF EXPANDED LIMBAL EPITHELIAL STEM CELLS
-
批准号:6951118
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2004
-
负责人:SCHEFFER CG TSENG
-
依托单位:
TRANSPLANTATION OF EXPANDED LIMBAL EPITHELIAL STEM CELLS
-
批准号:6804225
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2004
-
负责人:SCHEFFER CG TSENG
-
依托单位:
TRANSPLANTATION OF EXPANDED LIMBAL EPITHELIAL STEM CELLS
-
批准号:7118935
-
项目类别:
-
资助金额:$28.98万
-
财政年份:2004
-
负责人:SCHEFFER CG TSENG
-
依托单位:
TRANSPLANTATION OF EXPANDED LIMBAL EPITHELIAL STEM CELLS
-
批准号:7289241
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2004
-
负责人:SCHEFFER CG TSENG
-
依托单位:
DEVELOPMENT OF SUTURELESS AMNIOTIC MEMBRANE GRAFT
-
批准号:7051769
-
项目类别:
-
资助金额:$36.24万
-
财政年份:2003
-
负责人:SCHEFFER CG TSENG
-
依托单位:
DEVELOPMENT OF SUTURELESS AMNIOTIC MEMBRANE GRAFT
-
批准号:7282992
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2003
-
负责人:SCHEFFER CG TSENG
-
依托单位:
DEVELOPMENT OF SUTURELESS AMNIOTIC MEMBRANE GRAFT
-
批准号:6641000
-
项目类别:
-
资助金额:$10.31万
-
财政年份:2003
-
负责人:SCHEFFER CG TSENG
-
依托单位:
GROWTH AND DIFFERNTIATION OF OCULAR SURFACE EPITHELIA
-
批准号:3263513
-
项目类别:
-
资助金额:$18.02万
-
财政年份:1986
-
负责人:SCHEFFER CG TSENG
-
依托单位:
GROWTH AND DIFFERNTIATION OF OCULAR SURFACE EPITHELIA
-
批准号:3263509
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1986
-
负责人:SCHEFFER CG TSENG
-
依托单位:
Quiescence of Limbal Epithelial Stem Cells
-
批准号:9207155
-
项目类别:
-
资助金额:$37.59万
-
财政年份:1986
-
负责人:SCHEFFER CG TSENG
-
依托单位:
VITAMIN A AND CONJUNCTIVAL TRANSDIFFERENTIATION
-
批准号:3263508
-
项目类别:
-
资助金额:$20.19万
-
财政年份:1986
-
负责人:SCHEFFER CG TSENG
-
依托单位:
EX VIVO EXPANSION OF LIMBAL EPITHELIAL STEM CELLS
-
批准号:6198997
-
项目类别:
-
资助金额:$31.0万
-
财政年份:1986
-
负责人:SCHEFFER CG TSENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: